• Abiraterone Acetate Included in WHO’s Essential Medicines List americanpharmaceuticalreview
    July 22, 2019
    The Janssen Pharmaceutical Companies of Johnson & Johnson announced the World Health Organization (WHO) will include abiraterone acetate (ZYTIGA®) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medic
PharmaSources Customer Service